Found: 55
Select item for more details and to access through your institution.
The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 609, doi. 10.1093/oncolo/oyae107
- By:
- Publication type:
- Article
Role of sex in lung cancer risk prediction based on single low-dose chest computed tomography.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45671-6
- By:
- Publication type:
- Article
Phase II Study of Cabozantinib in Patients With Bone Metastasis.
- Published in:
- Oncologist, 2022, v. 27, n. 7, p. 600, doi. 10.1093/oncolo/oyac083
- By:
- Publication type:
- Article
Incidence of Radiation Therapy Among Patients Enrolled in a Multidisciplinary Pulmonary Nodule and Lung Cancer Screening Clinic.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 3, p. e224840, doi. 10.1001/jamanetworkopen.2022.4840
- By:
- Publication type:
- Article
Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at Progression.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 201, doi. 10.1016/j.cllc.2021.01.010
- By:
- Publication type:
- Article
Clinical and Imaging Features of Non-Small-Cell Lung Cancer in Young Patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Integrated, Multidisciplinary Management of Pulmonary Nodules Can Streamline Care and Improve Adherence to Recommendations.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 431, doi. 10.1634/theoncologist.2019-0519
- By:
- Publication type:
- Article
Computed Tomography Imaging Features and Distribution of Metastases in ROS1-rearranged Non-Small-cell Lung Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Patient Preferences for Use of Archived Biospecimens from Oncology Trials When Adequacy of Informed Consent Is Unclear.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 78, doi. 10.1634/theoncologist.2019-0365
- By:
- Publication type:
- Article
Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor‐Mutant Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1570, doi. 10.1634/theoncologist.2019-0158
- By:
- Publication type:
- Article
Diffuse Lung Metastases in EGFR-Mutant Non-Small Cell Lung Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1360, doi. 10.3390/cancers11091360
- By:
- Publication type:
- Article
Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild‐Type Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. 1095, doi. 10.1634/theoncologist.2018-0695
- By:
- Publication type:
- Article
Predicting malignant potential of subsolid nodules: can radiomics preempt longitudinal follow up CT?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Afatinib Therapy: Practical management of adverse events with an oral agent for non-small cell lung cancer treatment.
- Published in:
- Clinical Journal of Oncology Nursing, 2018, v. 22, n. 5, p. 542, doi. 10.1188/18.CJON.542-548
- By:
- Publication type:
- Article
Phase Ib Study of High-dose Intermittent Afatinib in Patients With Advanced Solid Tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Role of Epidermal Growth Factor Receptor (EGFR) Inhibitors and Radiation in the Management of Brain Metastases from EGFR Mutant Lung Cancers.
- Published in:
- Oncologist, 2018, v. 23, n. 9, p. 1054, doi. 10.1634/theoncologist.2017-0557
- By:
- Publication type:
- Article
Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-term safety and survival with gefitinib in select patients with advanced non-small cell lung cancer: Results from the US IRESSA Clinical Access Program (ICAP).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Osimertinib for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLC: Tolerability and Diagnostic Methods From an Expanded Access Program.
- Published in:
- Oncology & Therapy, 2018, v. 6, n. 1, p. 45, doi. 10.1007/s40487-018-0061-y
- By:
- Publication type:
- Article
Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-017-02261-1
- By:
- Publication type:
- Article
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01705-y
- By:
- Publication type:
- Article
Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 415, p. 1, doi. 10.1126/scitranslmed.aao4307
- By:
- Publication type:
- Article
AJRCCM: 100-Year Anniversary. The Shifting Landscape for Lung Cancer: Past, Present, and Future.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Expression of β-globin by cancer cells promotes cell survival during blood-borne dissemination.
- Published in:
- Nature Communications, 2017, v. 8, n. 2, p. 14344, doi. 10.1038/ncomms14344
- By:
- Publication type:
- Article
EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6.
- Published in:
- 2017
- By:
- Publication type:
- journal article
End-of-Life Care in Patients with Metastatic Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations.
- Published in:
- Journal of Palliative Medicine, 2016, v. 19, n. 12, p. 1316, doi. 10.1089/jpm.2016.0180
- By:
- Publication type:
- Article
Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.
- Published in:
- Nature Communications, 2016, v. 7, n. 11, p. 13513, doi. 10.1038/ncomms13513
- By:
- Publication type:
- Article
Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 8, p. 964, doi. 10.1634/theoncologist.2015-0508
- By:
- Publication type:
- Article
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.
- Published in:
- Nature Communications, 2016, v. 7, n. 6, p. 11815, doi. 10.1038/ncomms11815
- By:
- Publication type:
- Article
Continued EGFR Inhibition With Postprogression Chemotherapy: Where Do We Stand?
- Published in:
- 2015
- By:
- Publication type:
- Opinion
Delay of treatment change after objective progression on first-line erlotinib in epidermal growth factor receptor-mutant lung cancer.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 15, p. 2570, doi. 10.1002/cncr.29397
- By:
- Publication type:
- Article
The Anticipated Next Season of EGFR Inhibitors.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
Tunable Nanostructured Coating for the Capture and Selective Release of Viable Circulating Tumor Cells.
- Published in:
- Advanced Materials, 2015, v. 27, n. 9, p. 1593, doi. 10.1002/adma.201404677
- By:
- Publication type:
- Article
The Role of Third-Generation Epithelial Growth Factor Receptor Inhibitors in Non--Small Cell Lung Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2015, v. 13, n. 3, p. 147
- By:
- Publication type:
- Article
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer.
- Published in:
- Nature Communications, 2015, v. 6, n. 3, p. 6377, doi. 10.1038/ncomms7377
- By:
- Publication type:
- Article
Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 3, p. 448, doi. 10.1002/cncr.29042
- By:
- Publication type:
- Article
Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non–small cell lung cancer treated with radiotherapy for brain metastases.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 2, p. 296, doi. 10.1093/neuonc/nou146
- By:
- Publication type:
- Article
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 19, p. 1998, doi. 10.1001/jama.2014.3741
- By:
- Publication type:
- Article
Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 216, p. 1, doi. 10.1126/scitranslmed.3007205
- By:
- Publication type:
- Article
Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors.
- Published in:
- Oncologist, 2013, v. 18, n. 11, p. 1214, doi. 10.1634/theoncologist.2013-0168
- By:
- Publication type:
- Article
Corrigendum: RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis.
- Published in:
- 2012
- By:
- Publication type:
- Erratum
RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis.
- Published in:
- Nature, 2012, v. 487, n. 7408, p. 510, doi. 10.1038/nature11217
- By:
- Publication type:
- Article
Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers.
- Published in:
- Science Translational Medicine, 2012, v. 4, n. 120, p. 1, doi. 10.1126/scitranslmed.3003316
- By:
- Publication type:
- Article
Outcomes After Combined Modality Therapy for EGFR-Mutant and Wild-Type Locally Advanced NSCLC.
- Published in:
- Oncologist, 2011, v. 16, n. 6, p. 886, doi. 10.1634/theoncologist.2011-0040
- By:
- Publication type:
- Article
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 75, p. 1, doi. 10.1126/scitranslmed.3002003
- By:
- Publication type:
- Article
Role of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography in Predicting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2011, v. 16, n. 3, p. 319, doi. 10.1634/theoncologist.2010-0300
- By:
- Publication type:
- Article
EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 11, p. 1193, doi. 10.1093/neuonc/noq076
- By:
- Publication type:
- Article
Exciting new targets in lung cancer therapy: ALK, IGF-1R, HDAC, and Hh.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine.
- Published in:
- EMBO Molecular Medicine, 2010, v. 2, n. 5, p. 146, doi. 10.1002/emmm.201000070
- By:
- Publication type:
- Article